December 23, 2025 (MLN): The Board of Attock Refinery Limited (PSX: ATRL) is considering the disinvestment of its shareholding in its wholly owned subsidiary, Attock Hospital (Pvt.) Limited, as part of a move to concentrate on its core refining business.

As part of this consideration, Expressions of Interest may be sought to explore joint venture opportunities, the company’s filing on the PSX revealed today. 

Under such arrangements, management control could also be offered to a prospective partner on mutually agreed terms and conditions.

Any final decision regarding the proposed divestment or joint venture structure will be taken after a comprehensive evaluation of all available options and relevant factors.

At the time of writing, shares of ATRL were trading at Rs650.20, up Rs9.39, or 1.47%. 

Copyright